512 related articles for article (PubMed ID: 18206495)
1. D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma.
Rabban JT; Chen YY
Hum Pathol; 2008 Feb; 39(2):175-83. PubMed ID: 18206495
[TBL] [Abstract][Full Text] [Related]
2. Invasive lobular carcinoma of the breast: role of endothelial lymphatic marker D2-40.
Laser J; Cangiarella J; Singh B; Melamed J; Chiriboga L; Yee H; Darvishian F
Ann Clin Lab Sci; 2008; 38(2):99-104. PubMed ID: 18469353
[TBL] [Abstract][Full Text] [Related]
3. Role of E-cadherins in development of lymphatic tumor emboli.
Gupta A; Deshpande CG; Badve S
Cancer; 2003 May; 97(9):2341-7. PubMed ID: 12712492
[TBL] [Abstract][Full Text] [Related]
4. Epithelial displacement into the lymphovascular space can be seen in breast core needle biopsy specimens.
Koo JS; Jung WH; Kim H
Am J Clin Pathol; 2010 May; 133(5):781-7. PubMed ID: 20395526
[TBL] [Abstract][Full Text] [Related]
5. D2-40: an additional marker for myoepithelial cells of breast and the precaution in interpreting tumor lymphovascular invasion.
Ren S; Abuel-Haija M; Khurana JS; Zhang X
Int J Clin Exp Pathol; 2011 Jan; 4(2):175-82. PubMed ID: 21326813
[TBL] [Abstract][Full Text] [Related]
6. Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6.
Rabban JT; Koerner FC; Lerwill MF
Hum Pathol; 2006 Jul; 37(7):787-93. PubMed ID: 16784976
[TBL] [Abstract][Full Text] [Related]
7. Antibodies targeting p63 react specifically in the cytoplasm of breast epithelial cells exhibiting secretory differentiation.
Bratthauer GL; Saenger JS; Strauss BL
Histopathology; 2005 Dec; 47(6):611-6. PubMed ID: 16324199
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic alterations in ductal carcinoma in situ-associated myoepithelial cells: biologic and diagnostic implications.
Hilson JB; Schnitt SJ; Collins LC
Am J Surg Pathol; 2009 Feb; 33(2):227-32. PubMed ID: 18936688
[TBL] [Abstract][Full Text] [Related]
10. The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma?
Bagaria SP; Shamonki J; Kinnaird M; Ray PS; Giuliano AE
Ann Surg Oncol; 2011 Jul; 18(7):1845-51. PubMed ID: 21287281
[TBL] [Abstract][Full Text] [Related]
11. [Loss of fragile histidine triad expression and metastasis in breast cancer].
Zhao P; Li XY; Chen LZ
Ai Zheng; 2002 Jun; 21(6):668-70. PubMed ID: 12452072
[TBL] [Abstract][Full Text] [Related]
12. Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences.
Mohammed RA; Martin SG; Gill MS; Green AR; Paish EC; Ellis IO
Am J Surg Pathol; 2007 Dec; 31(12):1825-33. PubMed ID: 18043036
[TBL] [Abstract][Full Text] [Related]
13. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma.
Rasbridge SA; Gillett CE; Sampson SA; Walsh FS; Millis RR
J Pathol; 1993 Feb; 169(2):245-50. PubMed ID: 8383197
[TBL] [Abstract][Full Text] [Related]
14. Loss of myoepithelium is variable in solid papillary carcinoma of the breast.
Nicolas MM; Wu Y; Middleton LP; Gilcrease MZ
Histopathology; 2007 Nov; 51(5):657-65. PubMed ID: 17927587
[TBL] [Abstract][Full Text] [Related]
15. [Expression and prognostic value of transcriptional factor sp1 in breast cancer].
Wang XB; Peng WQ; Yi ZJ; Zhu SL; Gan QH
Ai Zheng; 2007 Sep; 26(9):996-1000. PubMed ID: 17927860
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain.
Werling RW; Hwang H; Yaziji H; Gown AM
Am J Surg Pathol; 2003 Jan; 27(1):82-90. PubMed ID: 12502930
[TBL] [Abstract][Full Text] [Related]
17. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
18. Immunohistological localisation of human FAT1 (hFAT) protein in 326 breast cancers. Does this adhesion molecule have a role in pathogenesis?
Kwaepila N; Burns G; Leong AS
Pathology; 2006 Apr; 38(2):125-31. PubMed ID: 16581652
[TBL] [Abstract][Full Text] [Related]
19. E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesions.
Goldstein NS; Bassi D; Watts JC; Layfield LJ; Yaziji H; Gown AM
Am J Clin Pathol; 2001 Apr; 115(4):534-42. PubMed ID: 11293901
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of p75 neurotrophin receptor (p75NTR) as a marker of breast myoepithelial cells.
Popnikolov NK; Cavone SM; Schultz PM; Garcia FU
Mod Pathol; 2005 Dec; 18(12):1535-41. PubMed ID: 16258511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]